These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1481022

  • 1. [Prostaglandin E1 in intermittent claudication].
    Scheffler P, de la Hamette D, Rogatti W.
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
    Horsch S, Claeys L, Diehm C, Rieger H, Cachovan M, Baitsch C.
    Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
    Ranke C, Creutzig A, Alexander K.
    Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
    [No Abstract] [Full Text] [Related]

  • 7. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Alexander K.
    Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

  • 10. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P, Kostewicz W, Górski G.
    Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P, Birkel L, Grub KR, de la Hamette D.
    Vasa Suppl; 1988 Oct; 23():126-9. PubMed ID: 3061035
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C.
    Vasa Suppl; 1991 Oct; 33():341-2. PubMed ID: 1788749
    [Abstract] [Full Text] [Related]

  • 14. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992 Oct; 35():36-8. PubMed ID: 1481055
    [No Abstract] [Full Text] [Related]

  • 15. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K.
    Med Klin (Munich); 1988 Jun 17; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract] [Full Text] [Related]

  • 16. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
    Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC.
    J Am Coll Cardiol; 1998 Nov 17; 32(5):1336-44. PubMed ID: 9809945
    [Abstract] [Full Text] [Related]

  • 17. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 18. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
    Heidrich H.
    Vasa Suppl; 1991 May 23; 33():346-7. PubMed ID: 1788752
    [Abstract] [Full Text] [Related]

  • 19. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1991 May 23; 33():343-4. PubMed ID: 1788750
    [Abstract] [Full Text] [Related]

  • 20. [Effect of prostaglandin E1 on neutrophilic granulocytes of patients with intermittent claudication].
    Weiss T, Neumann FJ, Mollenhauer J, Haupt HM, Diehm C.
    Vasa Suppl; 1991 May 23; 32():345-6. PubMed ID: 1771529
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.